Barclays reiterated their hold rating on shares of AmerisourceBergen (NYSE:ABC) in a report released on Sunday morning, AnalystRatings.com reports. Barclays currently has a $100.00 price target on the stock.
ABC has been the subject of a number of other research reports. ValuEngine downgraded shares of AmerisourceBergen from a hold rating to a sell rating in a research report on Friday, November 1st. Argus reissued a buy rating and issued a $110.00 price objective on shares of AmerisourceBergen in a research report on Monday, November 18th. Finally, TheStreet raised shares of AmerisourceBergen from a c+ rating to a b- rating in a research report on Friday, December 6th. Two analysts have rated the stock with a sell rating, four have assigned a hold rating and three have given a buy rating to the company’s stock. The company presently has a consensus rating of Hold and an average target price of $91.50.
Shares of ABC opened at $92.03 on Friday. The firm has a 50-day moving average of $86.61 and a 200-day moving average of $86.13. AmerisourceBergen has a one year low of $70.55 and a one year high of $94.75. The company has a market cap of $18.79 billion, a PE ratio of 12.89, a price-to-earnings-growth ratio of 1.63 and a beta of 0.96. The company has a debt-to-equity ratio of 1.45, a current ratio of 0.95 and a quick ratio of 0.58.
AmerisourceBergen (NYSE:ABC) last announced its quarterly earnings data on Thursday, November 7th. The company reported $1.61 EPS for the quarter, beating analysts’ consensus estimates of $1.58 by $0.03. AmerisourceBergen had a net margin of 0.48% and a return on equity of 48.84%. The company had revenue of $45.64 billion during the quarter, compared to the consensus estimate of $45.15 billion. During the same quarter last year, the firm posted $1.45 EPS. The company’s quarterly revenue was up 5.4% on a year-over-year basis. Analysts expect that AmerisourceBergen will post 7.53 earnings per share for the current year.
In related news, EVP John G. Chou sold 13,997 shares of AmerisourceBergen stock in a transaction dated Tuesday, November 5th. The shares were sold at an average price of $86.07, for a total transaction of $1,204,721.79. Also, CEO Steven H. Collis sold 19,905 shares of AmerisourceBergen stock in a transaction dated Monday, November 4th. The stock was sold at an average price of $86.08, for a total transaction of $1,713,422.40. Following the sale, the chief executive officer now directly owns 154,484 shares of the company’s stock, valued at approximately $13,297,982.72. The disclosure for this sale can be found here. Insiders have sold a total of 64,724 shares of company stock valued at $5,561,840 in the last ninety days. 27.80% of the stock is currently owned by insiders.
Hedge funds have recently made changes to their positions in the stock. LS Investment Advisors LLC boosted its holdings in shares of AmerisourceBergen by 6.7% during the 3rd quarter. LS Investment Advisors LLC now owns 12,856 shares of the company’s stock worth $1,058,000 after buying an additional 811 shares during the period. Voya Investment Management LLC raised its stake in AmerisourceBergen by 24.0% in the 3rd quarter. Voya Investment Management LLC now owns 290,573 shares of the company’s stock worth $23,923,000 after purchasing an additional 56,272 shares in the last quarter. Endurant Capital Management LP raised its stake in AmerisourceBergen by 43.5% in the 3rd quarter. Endurant Capital Management LP now owns 105,501 shares of the company’s stock worth $8,686,000 after purchasing an additional 31,998 shares in the last quarter. Mackenzie Financial Corp raised its stake in AmerisourceBergen by 1.8% in the 2nd quarter. Mackenzie Financial Corp now owns 68,493 shares of the company’s stock worth $5,840,000 after purchasing an additional 1,190 shares in the last quarter. Finally, Usca Ria LLC raised its stake in AmerisourceBergen by 0.5% in the 3rd quarter. Usca Ria LLC now owns 33,580 shares of the company’s stock worth $2,765,000 after purchasing an additional 171 shares in the last quarter. 66.72% of the stock is owned by institutional investors and hedge funds.
AmerisourceBergen Corporation sources and distributes pharmaceutical products in the United States and internationally. Its Pharmaceutical Distribution segment distributes brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, outsourced compounded sterile preparations, and related services to various healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and other alternate site pharmacies, and other customers.
Recommended Story: How is the discount rate different from the Federal Funds rate?
Receive News & Ratings for AmerisourceBergen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AmerisourceBergen and related companies with MarketBeat.com's FREE daily email newsletter.